Tempest Reports Inducement Grants Under Nasdaq Listing Rule 5635
HSTODelisted Stock | USD 0.03 0.00 0.00% |
About 55% of Histogen's investor base is interested to short. The analysis of current outlook of investing in Histogen suggests that many traders are impartial regarding Histogen's prospects. Histogen's investing sentiment overview a quick insight into current market opportunities from investing in Histogen. Many technical investors use Histogen stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Histogen |
BRISBANE, Calif., Sept. 20, 2024 -- Tempest Therapeutics, Inc. , a clinical-stage biotechnology company developing...
Read at globenewswire.com
![]() |
Histogen Fundamental Analysis
We analyze Histogen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Histogen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Histogen based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Owned By Insiders
Shares Owned By Insiders Comparative Analysis
Histogen is currently under evaluation in shares owned by insiders category among its peers. Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
Histogen Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Histogen stock to make a market-neutral strategy. Peer analysis of Histogen could also be used in its relative valuation, which is a method of valuing Histogen by comparing valuation metrics with similar companies.
Peers
Histogen Related Equities
PALI | Palisade Bio | 7.25 | ||||
VRAX | Virax Biolabs | 2.80 | ||||
SNTI | Senti Biosciences | 0.63 | ||||
TPST | Tempest Therapeutics | 0.60 | ||||
ARTL | Artelo Biosciences | 2.06 | ||||
TNXP | Tonix Pharmaceuticals | 5.25 | ||||
DRUG | Bright Minds | 6.25 | ||||
ENTX | Entera Bio | 7.28 | ||||
SONN | Sonnet Biotherapeutics | 7.69 | ||||
CING | Cingulate | 8.01 | ||||
CRIS | Curis | 9.43 |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Consideration for investing in Histogen Stock
If you are still planning to invest in Histogen check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Histogen's history and understand the potential risks before investing.
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |